Pantoprazole

Pantoprazole, the active ingredient in Pantoprazole, is a proton pump inhibitor presented as a injection for intravenous use. It reduces gastric acid secretion in patients with gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome.

GNH USA supplies Pantoprazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoprazole is a proton pump inhibitor used to manage conditions driven by excess gastric acid.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates mucosal repair and reduces further injury. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

Common Side Effects: - Headache: mild to moderate discomfort often reported during therapy. - Diarrhea: loose stools that may occur shortly after initiation. - Nausea: transient feeling of queasiness. - Abdominal pain: mild discomfort in the upper abdomen. - Constipation: reduced bowel movements in some patients.

Serious or Rare Side Effects: - Severe allergic reactions: anaphylaxis, angioedema, or skin rash requiring immediate medical attention. - Clostridioides difficile infection: colitis presenting with watery diarrhea. - Low serum magnesium or vitamin B12 deficiency: may develop with prolonged use and require monitoring.

Before using Pantoprazole, consider the following precautions: - Renal impairment: dose adjustment may be necessary in patients with reduced kidney function. - Hepatic impairment: monitor liver enzymes and adjust therapy if significant dysfunction is present. - Long‑term therapy: assess magnesium levels periodically to avoid deficiency. - Pregnancy: safety category unknown; use only when the potential benefit justifies the potential risk. - Drug interactions: review concomitant medications for possible interactions. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Pantoprazole may interact with several medications.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir or Nelfinavir: decreased absorption of these antivirals, reducing efficacy. - Methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: may raise serum digoxin levels, necessitating dose adjustment.